Pathogen-reduced platelets for the prevention of bleeding (Review)
BACKGROUND: Platelet transfusions are used to prevent and treat bleeding in patients who are thrombocytopenic. Despite improvements in donor screening and laboratory testing, a small risk of viral, bacterial or protozoal contamination of platelets remains. There is also an ongoing risk from newly em...
Päätekijät: | Butler, C, Doree, C, Estcourt, L, Trivella, M, Hopewell, S, Brunskill, S, Stanworth, S, Murphy, M |
---|---|
Aineistotyyppi: | Journal article |
Kieli: | English |
Julkaistu: |
Wiley
2013
|
Samankaltaisia teoksia
-
Pathogen-reduced platelets for the prevention of bleeding.
Tekijä: Butler, C, et al.
Julkaistu: (2013) -
Pathogen-reduced platelets for the prevention of bleeding (protocol)
Tekijä: Butler, C, et al.
Julkaistu: (2011) -
Pathogen-reduced platelets for the prevention of bleeding (Review)
Tekijä: Estcourt, L, et al.
Julkaistu: (2017) -
Pathogen-reduced platelets for the prevention of bleeding in people of any age
Tekijä: Estcourt, L, et al.
Julkaistu: (2018) -
Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation (Review)
Tekijä: Estcourt, L, et al.
Julkaistu: (2015)